Your Partner in Cardiometabolic Research
With deep expertise and established relationships, we build on our substantial cardiovascular CRO experience to address metabolic and endocrine disorders, delivering impact at every phase.
Simplifying Complexity, Driving Change
Cardiometabolic disease is the leading cause of death and disability in the world.
This underscores the urgent need for innovative and comprehensive cardiovascular clinical research that also addresses related endocrine and metabolic disorders, such as diabetes and obesity.
By tackling this interconnected spectrum of conditions, we provide better prevention, treatment, and management strategies.
Partner with us to develop trial approaches that target primary risk factors such as high blood pressure and cholesterol through drug and device interventions.
From Phase I through Phase IV, we support you at every step, ensuring seamless execution from early‑stage research to post‑marketing surveillance.
By integrating scientific leadership with end‑to‑end operational efficiency, we have a proven track record of driving real change in practice and policy.
Our extensive network of cardiovascular CRO experts helps us to deliver actionable insights that have a meaningful impact on global cardiometabolic health.
Strategic Leadership in Action
Jonathan Gobres BS Pharmacy
Jonathan designs bespoke, region‑specific strategies for trials across APAC and the rest of the world. With 28+ years of research experience, including 22+ years in clinical research across global pharma, biotech, and CROs, he brings program and customer management expertise in diabetes and other cardiometabolic diseases, oncology, and beyond.
Jonathan has led multiple global clinical trials to success, including a vaccine study that resulted in a worldwide product launch and a CNS program spanning Europe, the Americas, and APAC, which earned him accolades from sponsors.
Combining strategic vision with hands‑on leadership, Jonathan advances cardiometabolic clinical research, ensuring trials meet key endpoints while navigating complex regional landscapes.
Expert Cardiovascular CRO Solutions
Our comprehensive services span every stage and provide integrated solutions for cardiometabolic conditions. From protocol design to regulatory compliance, we tailor solutions to your unique needs.
With dedicated project managers ensuring seamless operations, our teams deliver efficiency and impact. Patient safety and trial integrity are priorities, supported by robust medical monitoring, endpoint adjudication, and real‑time pharmacovigilance.
Accurate data management and statistical analysis provide key insights, while our health economics expertise evaluates treatments’ broader impact.
With a global team in 40+ locations and diverse therapeutic expertise, partner with us to overcome challenges and advance clinical research.
Our areas of expertiseMeet our teamThe Cardiometabolic CRO Built for You
Whether you’re looking for individual cardiovascular CRO services or end‑to‑end cardiometabolic solutions, we deliver excellence at every stage.
Project Management
Drive progress with seamless coordination across functions and vendors throughout the trial lifecycle.
Clinical Trial Monitoring
Ensure patient safety, data integrity, and trial success through local expertise and oversight.
Data Management & Biostatistics
Get accurate, secure, and integrated solutions to maximize impact from start to finish.
Safety & Pharmacovigilance
Ensure patient safety with comprehensive risk management and surveillance strategies.
Frequently asked questions
What types of cardiometabolic trials can you support?
We deliver cardiometabolic clinical trials from early to late phases and post‑marketing surveillance. With extensive expertise in observational, interventional, and registry studies and a proven track record in cardiometabolic disease clinical research, we deliver excellence tailored to your needs. Request a proposal to learn how we can help you.
Can you support multi‑national or global cardiometabolic trials?
Absolutely. We have a strong presence worldwide with on‑the‑ground teams in 40+ locations and established roots in the APAC region. Our extensive global site relationships and on‑the‑ground therapeutic‑specific teams yield exceptional recruitment and retention rates across diverse patient populations. Local experts ensure cultural sensitivity and streamlined communication across all cardiometabolic CRO services.
What steps do you take to ensure compliance with evolving regulations?
We monitor regulatory changes globally and adapt strategies to maintain compliance. Our dedicated team stays updated on evolving standards, liaises with local authorities, and proactively adjusts documentation, processes, and timelines so you can be confident that your trial aligns with the latest requirements in every region. Visit Regulatory Consulting for more information.
What other therapeutic areas do you support?
We bring deep expertise across a wide range of therapeutic areas, from neurology and respiratory diseases to endocrinology and medical devices, with specialized leadership in renal, cardiometabolic, and oncology trials. We’re your partner in advancing impactful therapies that transform lives worldwide, delivering innovative, patient‑centric solutions. Visit Therapeutic Expertise for more information.
Cardiometabolic Impact & Insights
Take a look at recent advancements and see how our expertise drives breakthroughs in cardiometabolic research to improve patient outcomes globally.
Recognizing Cardiometabolic Excellence
See how our team earned a Citeline finalist spot for COVID-19 research in patients with cardiometabolic risk factors.
Tackling Type 2 Diabetes Comorbidities
Discover how the landmark CREDENCE trial addressed the rising burden of cardio‑renal‑metabolic diseases.